GLP-1 Receptor Agonist Analog (SMA designation) is supplied as compressed tablets, 500mcg strength, in 25-tablet containers designed for dose-escalation and microdosing research applications. This low-dose tablet formulation supports pharmacokinetic profiling at submilligram peptide quantities.

Chemical Composition:

• Chemical Name: GLP-1 Receptor Agonist Analog (tablet formulation, low-dose)
• Molecular Formula: C195H305N51O60S7 (representative structure; active ingredient)
• Molecular Weight: ~4,113 g/mol (active ingredient, approximate)
• Compound Class: GLP-1 receptor agonist; low-dose tablet research compound

The 500mcg tablet strength enables microdosing studies, evaluation of threshold concentrations for GLP-1 receptor activation, investigation of dose-linearity across wide concentration ranges, and assessment of tissue accumulation patterns at sub-saturating doses. Research encompasses evaluation of minimal effective dose for GLP-1 receptor engagement, investigation of receptor occupancy-response relationships, assessment of dose-dependent differential gene expression in metabolic tissues, and characterization of pharmacodynamic effects at very low receptor occupancy states in preclinical models.

Research Applications:

• Minimum effective dose determination via receptor occupancy studies
• GLP-1 receptor EC50 refinement using ultra-low dose tablet administration
• Dose-linear pharmacokinetics assessment across 500mcg-20mg range
• Tissue-specific GLP-1 receptor occupancy mapping at low-dose conditions
• Transcriptomic profiling of early-response genes at threshold activation levels

Storage and Handling:

• Store tablets at 15-25°C in dry, cool conditions; protect from light
• Maintain tablets in original container with desiccant for moisture protection
• Keep container tightly sealed to prevent moisture absorption
• Handle tablets with clean, dry hands; avoid crushing prior to use

Product Specifications:

• Form: Compressed tablets
• Strength: 500mcg per tablet
• Quantity: 25 tablets per container
• Purity: >95% (GLP-1 agonist analog content)
• Appearance: White to off-white small tablets

FOR RESEARCH USE ONLY. Not intended for human consumption or clinical use. All products are sold strictly for laboratory, educational, and scientific research purposes.